Maher Masoud, CEO

April 9 | 2:00pm | Salone dei Cavalieri, Section 3&4

Rockville, MD


MaxCyte is a leading cell-engineering company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support innovative, cell-based research. MaxCyte builds best-in-class technology designed to facilitate complex engineering of a wide variety of cells and to drive the rapidly expanding cell therapy market forward. For over 20 years, MaxCyte has been a leader in developing transfection workflows and ventures beyond today’s processes to innovate tomorrow’s solutions.

By using this website you agree to accept our Privacy Policy and Terms & Conditions